News Archivi

Tutto

21.06.2023

CoreeGroup chooses Italy to study a probiotic that enhances the immune response

Coree Italy’s commitment to the study of new natural enhancers of mucosal vaccinations CoreeGroup chooses Italy to study a probiotic that enhances the immune response The new preparation will be studied, in particular, to be combined as a “booster” to mucosal vaccination, a form of vaccine administration such as that using nasal sprays or oral drops that offers many advantages: […]

19.06.2023

Coree Pohang announce the DX24 App

Coree Pohang, a provider of digital healthcare solutions, recently announced that its remote medical service for Koreans living abroad, known as DX24, has obtained temporary authorization from the 1st Industry Convergence Regulatory Special Deliberation Committee this year. The Ministry of Trade, Industry, and Energy presented Coree Pohang with the original copy of the temporary permit on the 25th. DX24 is […]

22.05.2023

Ofmom partecipates in Policlinico Kids

We are pleased to announce our participation in the fourth edition of Policlinico Kids (organized by the Italian Society of Paediatrics) to be held from 24 to 25 May at the University of Milan in Via Festa del Perdono 7. We look forward to meeting you to discuss the infant microbiota and introduce you to the Ofmom line.

03.05.2023

Ofmom participates in Vitafoods Europe 2023

We are pleased to announce our presence at Vitafoods Europe 2023, the global nutraceutical event that annually attracts over 25,000 industry experts from over 130 countries. Vitafoods Europe will take place at Palexpo in Geneva, from 9 to 11 May, and you can come and discover the Ofmom world at stand L250/5. All those who are interested in meeting us […]

17.02.2023

Ofmom participates in the 12th edition of the congress “La pediatria nella pratica clinica”

From 2 to 4 February, the twelfth edition of the ‘Paediatrics in Clinical Practice’ congress was held at the Palazzo delle stelline in Milan. A 3-day event where we had the opportunity to talk to doctors, pediatricians, and health professionals about the changes that have characterized relationships with families in recent years and to present them with SYNTERACT™ BIMBI 14 […]

06.05.2022

Global Vaccine Hub「KHUB Science Park」Full-scale Promotion in Pohang City

– Hanmi Pharmaceutical President, Lim Chong-yoon, established a public interest foundation for a global standard vaccine research and production facility in Pohang City. – Pohang city is expected to grow as a center for bio/vaccine/healthcare research and production. Pohang City announced that KHUB Science Park, which is a non-profit public interest research foundation led by the president of Hanmi Pharmaceutical […]

24.02.2022

Hanmi Pharm Set to Produce COVID-19 Treatment for Merck and Supply to Developing Countries

Hanmi Pharmaceutical is set to manufacture a generic drug of Merck’s oral COVID-19 treatment drug and supply it to underdeveloped countries. On January 20th, Hanmi Pharmaceutical announced that it has recently signed a production agreement with the Medicines Patent Pool (MPP) for granting the right to produce molnupiravir (brand name: Lagevrio) developed by Merck of the United States. Under this […]

07.02.2022

Hanmi Pharm Set to Produce DNA-based COVID-19 Vaccine Developed by Zydus Cadila

Hanmi Pharmaceutical announced that it would begin the production of ZyCoV-D, the COVID-19 plasmid DNA vaccine, developed by Indian pharmaceutical company Zydus Cadila (Zydus). To this end, Hanmi Pharm signed a contract for the technology transfer and facility preparation for consignment manufacturing of the ZyCoV-D vaccine with Enzychem Life Sciences on January 7. Enzychem signed a technology transfer agreement with […]

16.11.2021

Chong Yoon Lim, CEO of Hanmi Science, announces addition of eWorldwide Group to Hanmi Science Consortium and invites other groups to join

As G20 Explores Vaccine Equity, Hanmi Science Consortium Pushes Forward with Vaccine Equity Initiative. In his recent opening address to the G20, Italian Prime Minister Mario Draghi highlighted vaccine inequity, emphasizing the fact that only 3% of eligible people living in the world’s poorest nations had received any form of COVID-19 vaccine, versus more than 70% in high-income countries. Mr. […]